PRecisiOn MEdicine to Target Frailty of Endocrine-metabolic Origin

NCT04856683 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1100

Last updated 2022-11-23

No results posted yet for this study

Summary

This is a multicenter, observational, retrospective and prospective study for the evaluation of precision medicine to target frailty of endocrine-metabolic origin, with a genetic study.

Conditions

Sponsors & Collaborators

  • University of Roma La Sapienza

    lead OTHER

Principal Investigators

  • Andrea M Isidori, Prof · Department of Experimental Medicine, "Sapienza" University of Rome

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-10
Primary Completion
2023-08-31
Completion
2024-08-09

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04856683 on ClinicalTrials.gov